InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.06
(
-0.09%
)
Bitcoin
66,235.67
(
-0.61%
)
Post# of 252214
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

rwwine

Send PM Follow Ignore
Followers 11
Posts 878
Boards Moderated 0
Alias Born 10/27/2003

rwwine

Re: DewDiligence post# 248228

Friday, 07/28/2023 9:27:37 AM

Friday, July 28, 2023 9:27:37 AM

Post# of 252214
“To maximize the opportunity, however, RVNC will need a partner to co-market Daxxify for therapeutic indications.”

We are essentially three weeks from an FDA ruling on “potential” approval for CD. It strikes me odd there has been no announcement on a partner for sales into this medical/therapeutic indication. I sure hope the Executives are laser focused on launching immediately for CD pending approval.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up